Circulating endothelial cells in vascular disorders: new insights into an old concept

F Dignat-George1, J Sampol

  • 1Laboratory of Hematology and Immunology, INSERM EMI 00-19, UFR de Pharmacie, Université de la Méditerranée, Marseille, France. hematim@pharmacie.univ-mrs.fr

Insights

Researchers developed a new method to count circulating endothelial cells (CECs) in blood, aiding in the diagnosis and monitoring of vascular disorders and infectious diseases.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Pathology

Background:

  • Endothelial cells play a crucial role in vascular health and disease.
  • Investigating endothelial involvement in human pathology is challenging due to limited noninvasive methods and specific markers.
  • Circulating endothelial cells (CECs) in peripheral blood offer a direct window into endothelial status.

Purpose of the Study:

  • To develop a method for enumerating circulating endothelial cells (CECs) in human blood.
  • To establish CECs as a potential biomarker for vascular injury and disease.
  • To explore the diagnostic and prognostic value of CEC enumeration in various clinical conditions.

Main Methods:

  • Production of a monoclonal antibody (S-Endo 1) targeting CD146, a specific endothelial cell marker.
  • Development of a sensitive immunocapture assay using the S-Endo 1 antibody.
  • Quantification of CECs in peripheral blood samples from patients with thrombotic, infectious, or immunological disorders and healthy subjects.

Main Results:

  • The S-Endo 1 antibody specifically recognizes human endothelial cells, excluding hematopoietic cells.
  • The immunocapture test detected significantly higher numbers of CECs in patients with vascular disorders compared to healthy individuals (< 3/ml).
  • Elevated CEC levels were observed in thrombotic, infectious, and immunological conditions.

Conclusions:

  • CEC enumeration is a valuable quantitative approach for assessing vascular wall injury.
  • CEC counts can aid in the clinical follow-up of vascular disorders and evaluation of therapeutic efficacy.
  • CEC analysis offers potential for diagnosing infectious diseases and understanding endothelial cell properties in pathology.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...